Intracoronary stenting and additional results achieved by shockWAVE coronary lithotripsy: design and rationale of ISAR-WAVE trial.
Salvatore Cassese, Fiorenzo Simonetti, Hector Alfonso Alvarez Covarrubias...
https://pubmed.ncbi.nlm.nih.gov/39710352/Actively Recruiting
Led by Deutsches Herzzentrum Muenchen · Updated on 2026-01-06
666
Participants Needed
22
Research Sites
13 weeks
Total Duration
Researchers are evaluating the effectiveness, safety, and economic benefits of coronary lithotripsy compared to other lesion preparation methods like cutting or super high pressure balloon angioplasty and ablative procedures. The study focuses on treatment of severely calcified coronary artery stenoses in patients with coronary artery disease. It is a randomized, double-blind trial sponsored by Deutsches Herzzentrum Muenchen. Participants receive lesion preparation either by intravascular lithotripsy using balloons with a rated burst pressure of up to 18 atm or by other standard methods such as high, super high, cutting balloons, and ablative techniques. These procedures are performed before intracoronary stenting. The trial compares these approaches to assess additional benefits in treating severely calcified coronary lesions. During the study, participants are monitored for major cardiac and cerebrovascular events over 12 months after randomization. Researchers also track mortality, myocardial infarction, stroke, need for vessel revascularization, stent thrombosis, hospitalization for acute coronary syndrome, and bleeding events. Symptom assessments for physical and mental health related to coronary heart disease and medical costs are also evaluated. Safety and procedural success are closely observed throughout the study period.
CONDITIONS
Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy
S
Salvatore Cassese, MD, PHD
T
Thorsten Kessler, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Deutsches Herzzentrum Muenchen
Lead Sponsor
Gemeinsamer Bundesaussschuss
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure at enrollment
Participants receive lesion preparation using either coronary intravascular lithotripsy or other standard methods such as cutting or super high pressure balloons and/or ablative procedures.
1 procedure visit (in-person)
Duration - 12 months
Participants are followed for safety and effectiveness outcomes including cardiac events and need for revascularization for up to 12 months after the procedure.
Visits scheduled periodically over 12 months
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Salvatore Cassese, Fiorenzo Simonetti, Hector Alfonso Alvarez Covarrubias...
https://pubmed.ncbi.nlm.nih.gov/39710352/Deutsches Herzzentrum Muenchen
Lead Sponsor
Gemeinsamer Bundesaussschuss
Collaborating Sponsor